Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
NexQloud's Distributed Cloud Platform (DCP) Meets Hyperscale Datacenter Security Standard, Earning SOC 2® Type 1 in Just 3 Months
-
ARTEX – Strategic Partnership with Abaxx Technologies
-
nvp capital Crosses $200M in AUM with Second Fund to Back Vertical AI Founders Transforming Legacy Industries
-
Anfield Energy’s Milestone Purchase: First Major Underground Haul Truck Acquisition
-
Xali Gold Agrees to Transfer the El Oro Tailings Project in Mexico to Kappes, Cassiday
-
KP Tissue declares a Quarterly Dividend of $0.18 per Common Share
-
KP Tissue Releases Third Quarter 2025 Financial Results
-
Chicago Atlantic BDC, Inc. Reports Third Quarter 2025 Financial Results
-
Prosafe SE: Shareholding disclosure
-
New Fig Data: 94% of Canadians Say Talking About Money Struggles Should Be More Acceptable
-
Aura Biosciences Reports Third Quarter 2025 Financial Results and Business Highlights
-
Bonterra Energy Announces Third Quarter 2025 Financial Results and Operations Update
-
Abaxx Technologies Acquires Strategic Position in ARTEX AG, Extending Capabilities in Europe and to New Markets in Fine Art
-
Marigold PR Launches PRplus for the AI Era
-
Aebi Schmidt Group achieves significant step-up in profitability following the integration of the Shyft Group; strong order momentum and continued backlog growth
-
Broadwind Announces Third Quarter 2025 Results
-
American Shared Hospital Services Reports Third Quarter 2025 Financial Results
-
Opus Genetics Announces Dosing of First Participant in OPGx-BEST1 Phase 1/2 Gene Therapy Clinical Trial for Best Disease
-
Instil Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
IonQ, AMD and Qualcomm Ventures Join Classiq Strategic Up-Round
-
Sitryx to participate in upcoming healthcare investor conferences
-
Phaos Technology Announces Pricing of Initial Public Offering
-
Mobilicom Provides Third Quarter 2025 Update and Financial Highlights: Substantial Increase in Sales to U.S. Market
-
Applied Therapeutics Reports Third Quarter 2025 Financial Results
-
Siris Announces Transition of Managing Partner Peter Berger to Chairman
-
Mangoceuticals Partners with Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity Management
-
Mutuum Finance (MUTM) Advances Toward V1 Launch as Phase 6 Crosses 90% With Over 18k Investors
-
Beamr Issues Q3-2025 CEO Letter to Shareholders: Advancing the Commercial Pipeline in the Autonomous Vehicles Industry
-
GoHealth Prioritizes Retention, Quality, and Strategic Flexibility as Medicare Advantage Market Rationalizes; Reports Third Quarter 2025 Results
-
Bitfarms Reports Third Quarter 2025 Results
-
Plug to Broadcast 2025 Symposium on November 18, 2025
-
Intchains Group Limited To Acquire a Proof-of-Stake Technology Platform, and Expand Blockchain Infrastructure Capabilities
-
Traws Pharma Reports Third Quarter 2025 Results and Business Highlights
-
Newton Golf Company Reports Third Quarter 2025 Results
-
Uber Freight Invests in Last Mile, Expands Commercial Partnership with Better Trucks
-
Prospect’s Real Estate Credit Strategy Now Available to Approximately 176,000 Financial Representatives and Advisors via Digital Alternatives Platforms iCapital, SUBSCRIBE, and SEI Access
-
10 Barrel Pub Beer Taps Big Buck Hunter for Epic Cheap Fun Hunting SZN – Limited Edition Cans, Dive Bar Prizes, and $10,000 Arcade Giveaway Ignite Pacific Northwest
-
Evoke Pharma Reports Third Quarter 2025 Financial Results and Provides Business Update
-
Regeneron Highlights Progress at American Society of Hematology (ASH), with Updated Data in Multiple Myeloma, Lymphoma and Paroxysmal Nocturnal Hemoglobinuria Programs
-
Medicenna Therapeutics Reports Second Quarter Fiscal 2026 Financial Results and Provides a Corporate Update
-
OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with Two New Product Launches
-
Venus Concept Announces Third Quarter 2025 Financial Results
-
Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes
-
Malibu Boats, Inc. Announces Appointment of David Black to Chief Financial Officer
-
Chicago Atlantic BDC, Inc. Declares $0.34 Cash Dividend for Fourth Quarter 2025
-
Adagene Announces Licensing Agreement with Third Arc Bio for Development of Two Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology
-
OTC Markets Group Welcomes OceanaGold (Philippines), Inc. to OTCQX
-
25 Companies Earn Spot on the 2025 Fortune World’s Best Workplaces List
-
Aspo Plc - Managers' Transactions – Kaarina Ståhlberg
-
CHARM Therapeutics advances CHM-029, a next-generation menin inhibitor designed to overcome resistance mutations, as its first clinical candidate for acute myeloid leukaemia (AML)

